Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bernhard Kratzer

Showing results (11-20 of 33) with videos related to

Pageof 4
Sort By:
ACS Synthetic Biology|April 12, 2021
Directed Evolution of Stabilized Monomeric CD19 for Monovalent CAR Interaction Studies and Monitoring of CAR-T Cell PatientsElisabeth Laurent, Anna Sieber, Benjamin Salzer, et al.
International Archives of Allergy and Immunology|June 6, 2023
Mycobacterium avium Complex Infections: Detailed Phenotypic and Functional Immunological Work-Up Is Required despite Genetic AnalysesBernhard Kratzer, Katharina Grabmeier-Pfistershammer, Doris Trapin, et al.
Vaccines|March 26, 2022
Lack of Induction of RBD-Specific Neutralizing Antibodies despite Repeated Heterologous SARS-CoV-2 Vaccination Leading to Seroconversion and Establishment of T Cell-Specific Memory in a Patient in Remission of Multiple MyelomaBernhard Kratzer, Doris Trapin, Pia Gattinger, et al.
Frontiers in Immunology|December 11, 2023
Adoptive transfer of allergen-expressing B cells prevents IgE-mediated allergyLisa Prickler, Ulrike Baranyi, Konstantinos Mengrelis, et al.
Ebiomedicine|April 22, 2018
Genetic restriction of antigen-presentation dictates allergic sensitization and disease in humanized miceAlina Neunkirchner, Bernhard Kratzer, Cordula Köhler, et al.
Vaccines|March 28, 2024
Vaccine Based on Recombinant Fusion Protein Combining Hepatitis B Virus PreS with SARS-CoV-2 Wild-Type- and Omicron-Derived Receptor Binding Domain Strongly Induces Omicron-Neutralizing Antibodies in a Murine ModelPia Gattinger, Bernhard Kratzer, Al Nasar Ahmed Sehgal, et al.
Frontiers in Immunology|April 24, 2023
The small molecule inhibitor BX-795 uncouples IL-2 production from inhibition of Th2 inflammation and induces CD4<sup>+</sup> T cells resembling iTregPeter A Tauber, Bernhard Kratzer, Philipp Schatzlmaier, et al.
Allergy|July 24, 2018
Prevention of allergy by virus-like nanoparticles (VNP) delivering shielded versions of major allergens in a humanized murine allergy modelBernhard Kratzer, Cordula Köhler, Sandra Hofer, et al.
Frontiers in Immunology|November 19, 2021
Preventive Administration of Non-Allergenic Bet v 1 Peptides Reduces Allergic Sensitization to Major Birch Pollen Allergen, Bet v 1Oluwatoyin Akinfenwa, Huey-Jy Huang, Birgit Linhart, et al.
Allergy|March 31, 2022
Vaccine based on folded receptor binding domain-PreS fusion protein with potential to induce sterilizing immunity to SARS-CoV-2 variantsPia Gattinger, Bernhard Kratzer, Inna Tulaeva, et al.
Pageof 4

Showing results (11-20 of 33) with videos related to

Sort By:
Pageof 4
ACS Synthetic Biology|April 12, 2021
Directed Evolution of Stabilized Monomeric CD19 for Monovalent CAR Interaction Studies and Monitoring of CAR-T Cell PatientsElisabeth Laurent, Anna Sieber, Benjamin Salzer, et al.
International Archives of Allergy and Immunology|June 6, 2023
Mycobacterium avium Complex Infections: Detailed Phenotypic and Functional Immunological Work-Up Is Required despite Genetic AnalysesBernhard Kratzer, Katharina Grabmeier-Pfistershammer, Doris Trapin, et al.
Vaccines|March 26, 2022
Lack of Induction of RBD-Specific Neutralizing Antibodies despite Repeated Heterologous SARS-CoV-2 Vaccination Leading to Seroconversion and Establishment of T Cell-Specific Memory in a Patient in Remission of Multiple MyelomaBernhard Kratzer, Doris Trapin, Pia Gattinger, et al.
Frontiers in Immunology|December 11, 2023
Adoptive transfer of allergen-expressing B cells prevents IgE-mediated allergyLisa Prickler, Ulrike Baranyi, Konstantinos Mengrelis, et al.
Ebiomedicine|April 22, 2018
Genetic restriction of antigen-presentation dictates allergic sensitization and disease in humanized miceAlina Neunkirchner, Bernhard Kratzer, Cordula Köhler, et al.
Vaccines|March 28, 2024
Vaccine Based on Recombinant Fusion Protein Combining Hepatitis B Virus PreS with SARS-CoV-2 Wild-Type- and Omicron-Derived Receptor Binding Domain Strongly Induces Omicron-Neutralizing Antibodies in a Murine ModelPia Gattinger, Bernhard Kratzer, Al Nasar Ahmed Sehgal, et al.
Frontiers in Immunology|April 24, 2023
The small molecule inhibitor BX-795 uncouples IL-2 production from inhibition of Th2 inflammation and induces CD4<sup>+</sup> T cells resembling iTregPeter A Tauber, Bernhard Kratzer, Philipp Schatzlmaier, et al.
Allergy|July 24, 2018
Prevention of allergy by virus-like nanoparticles (VNP) delivering shielded versions of major allergens in a humanized murine allergy modelBernhard Kratzer, Cordula Köhler, Sandra Hofer, et al.
Frontiers in Immunology|November 19, 2021
Preventive Administration of Non-Allergenic Bet v 1 Peptides Reduces Allergic Sensitization to Major Birch Pollen Allergen, Bet v 1Oluwatoyin Akinfenwa, Huey-Jy Huang, Birgit Linhart, et al.
Allergy|March 31, 2022
Vaccine based on folded receptor binding domain-PreS fusion protein with potential to induce sterilizing immunity to SARS-CoV-2 variantsPia Gattinger, Bernhard Kratzer, Inna Tulaeva, et al.
Pageof 4